California-based health care provider Sutter Health and a Sacramento surgical practice group have agreed to pay a combined $46 million to resolve whistleblower allegations the doctors received kickbacks in exchange for referring patients to Sutter, the U.S. Department of Justice announced Friday.
The Trump administration proposed a rule Friday that would require health insurance plans to publicize their in-network and out-of-network rates and post cost-sharing information online by request.
A Florida jury has cleared an OB-GYN clinic of a patient's claims that its doctors’ negligence let her ectopic pregnancy slip through the cracks, causing her to lose her only Fallopian tube.
An Oklahoma judge formally slashed Johnson & Johnson's $572 million defeat in the nation's first opioid-crisis trial to $465 million Friday after acknowledging an astonishing arithmetic error.
Motley Rice LLC’s Joseph Rice speaks to Law360 about the ongoing multidistrict litigation over the opioid crisis, which has resulted in settlements worth $260 million so far, as well as the changes in jury verdicts and the law he has seen over the years.
A Florida appeals court on Friday affirmed a defense verdict in a suit seeking to hold a hospital liable for a patient’s sexual assault, saying the trial judge didn’t err by excluding hospital records regarding past sexual assault incidents.
Indivior can’t shed an indictment alleging it engaged in fraudulent opioid marketing just because prosecutors gave a grand jury evidence about a doctor’s unrelated fraud convictions, a Virginia federal judge has ruled, saying the company’s concerns about guilt by association were overstated.
An Oregon appeals court blocked the state's temporary ban on flavored cannabis vaping products, about a month after it took similar action on a ban on flavored nicotine vaping products.
Bankrupt drugmaker Purdue Pharma LP told a New York bankruptcy court Friday that its plan to pay the expenses of state governments participating in a settlement of claims related to Purdue’s role in the opioid epidemic is a sound exercise of its business judgment and is essential to the Chapter 11 case.
Sens. Tom Udall, D-N.M., and Lisa Murkowski, R-Alaska, put forward legislation Friday that aims to address health care staffing shortages at the Indian Health Service by providing tax breaks for two education programs.
The U.S. Department of Justice's controversial crusade against disfavored False Claims Act suits appears to be on increasingly solid ground after a series of court decisions allowing the DOJ to end whistleblower FCA cases. Here, Law360 spotlights five key takeaways from the government's recent success.
A group of retailers that bought the hormonal birth control pill Loestrin will be allowed to split their claims from the rest of the direct purchaser class in the upcoming trial over whether two pharmaceutical companies worked together to keep generic versions of the pill off the market.
The U.S. Food and Drug Administration should affirm that CBD is legal and develop rules for marketing dietary supplements that contain the newly legal but mostly unregulated chemical, a trade group told the agency in a letter on Thursday.
The San Carlos Apache Tribe hit the Indian Health Service with a complaint in Arizona federal court Thursday, alleging the IHS failed to cover millions of dollars of costs and lost revenue stemming from the health care coverage the tribe provided under contract with the agency.
Eleven firms are set to steer six initial public offerings that could raise $616 million in the week of Nov. 18 — the market's last full week before the Thanksgiving break — led by a real estate investment trust, a cryptocurrency miner and two acquisition-hungry blank check companies.
The cannabis industry is going big on lobbying this year, hoping to make strides toward resolving conflicting federal and state regulations it says are impeding the booming, multibillion-dollar legal retail cannabis market from growing like other American industries.
A nursing facility in San Antonio will have a chance to convince the Texas Supreme Court that a $3.4 million medical malpractice judgment against it, already reduced from a jury’s $13.9 million award, should be lowered again because the trial court used the wrong formula to calculate how settlement credits should apply.
A California federal jury found Friday that anti-abortion activists led by David Daleiden violated state and federal laws when they surreptitiously recorded Planned Parenthood's clinics and abortion providers and then posted the video footage online, awarding the organization over $2 million in compensatory and punitive damages.
The Massachusetts Supreme Judicial Court on Thursday upheld a pair of lower court rulings that said the governor overstepped his authority in rolling out a ban on the sale of vaping products, but left the controversial measure in place as the legal fight continues.
A bill introduced Friday by Sen. Cory Booker aims to form a federal agency that determines drug prices and empowers the U.S. Department of Health and Human Services to penalize companies that charge more by voiding patents or stripping their right to exclusively market a drug.
The past week in London has seen Libya's sovereign wealth fund sue Credit Suisse amid a long-running bribery battle, retailer Sports Direct take on its former accountant Grant Thornton, and a host of underwriters file claims against a shipowner and its bank a month after winning a case over a fake pirate attack. Here, Law360 looks at those and other new claims in the U.K.
Bankrupt drugmaker Insys Therapeutics told a Delaware judge Thursday that it would be moving forward with an amended Chapter 11 plan of liquidation after it failed to reach consensus with all creditor parties on how the estate’s assets should be distributed.
A former health care advertising company executive faces parallel criminal charges and civil claims over a multi-pronged advertising fraud scheme targeting the company’s clients, federal prosecutors and regulators said Thursday.
A day after the University of Pittsburgh Medical Center urged the Pennsylvania high court to reconsider its recent ruling that found the state’s seven-year hard deadline for medical malpractice lawsuits to be unconstitutional, three doctors groups on Thursday chimed in to support UPMC’s bid.
The U.S. Department of Health and Human Services said Thursday that it’s investigating Google’s collaboration with hospital giant Ascension, which purportedly allowed the powerful tech company to gather health data on millions of Americans.
As part of their business-collections strategy, noncontracted medical providers are increasingly using quasi-contract theories of recovery to sue payors. But before leaping to settlement, payors should consider the viability of certain defense strategies, say attorneys at Troutman Sanders.
To respond to the rapidly evolving legal landscape, companies that incorporate biometric data into their business practices can take several steps to minimize the risk of privacy litigation exposure, say Jeffrey Rosenthal and David Oberly of Blank Rome.
While there are only three state biometric privacy laws on the books, there is a growing trend of states' introducing biometric privacy bills, many of which feature far-reaching private right of action provisions that would substantially increase the level of regulatory and litigation risk, say Jeffrey Rosenthal and David Oberly of Blank Rome.
Recent federal appellate and district court rulings suggest that the predicted radical curtailing of Auer deference in the wake of the U.S. Supreme Court's decision in Kisor v. Wilkie has not come to fruition, say Jeffrey Karp and Edward Mahaffey at Sullivan & Worcester.
As Texas and other states review their judicial election processes, they would be well served by taking guidance from Massachusetts' Governor’s Council system, which protects the judiciary from the hazards of campaigning, says Richard Baker of New England Intellectual Property.
As Medicare payments for genetic testing rise, recent federal indictments over related fraud schemes suggest that a crackdown is already underway, says Alexander Owens of Pietragallo Gordon.
The Washington state cannabis industry has to abide by emergency rules passed in response to a very real health crisis, but there is no evidence, nor have there even been claims, of a connection between flavored cannabis vapor products and the outbreak of lung illnesses, says Samuel Mendez of Lane Powell.
Reading Jeffrey Rosen’s "Conversations With RBG: Ruth Bader Ginsburg on Life, Love, Liberty, and Law" is like eavesdropping on the author and his subject while they discuss how the restrained judicial minimalist became the fiery leader of the opposition, says Ninth Circuit Judge M. Margaret McKeown.
Following recent legislative developments — such as a Texas law that expands patient access to medical marijuana and proposed amendments to the federal Controlled Substances Act — many Texas employers are questioning whether to continue cannabis testing because it has become somewhat problematic, says Stephen Roppolo at Fisher Phillips.
A recent report from Germany’s Data Ethics Commission suggests a legal future for artificial intelligence that may look a lot like the European Union’s General Data Protection Regulation — sweeping in scope, focused on individual rights and corporate accountability, and applicable across all industries, say attorneys at Debevoise.
The U.S. Food and Drug Administration's new software-related guidance is largely consistent with previous drafts, but makes a variety of technical changes and clarifications to the FDA’s interpretation of the 21st Century Cures Act exemptions for certain software functions, say attorneys at Akin Gump.
In this month's bid protest roundup, Victoria Angle and Roke Iko at Morrison & Foerster look at three October decisions: The U.S. Court of Federal Claims considered its jurisdiction, the Federal Circuit looked at standing, and the U.S. Government Accountability Office clarified its scope of review over AbilityOne procurement protests.
To address the California Consumer Privacy Act’s two-part health care exception, which leaves large gaps of uncertainty for many next-generation health care companies, there are several compliance steps that can be used to assess the applicability of the CCPA, says Ryan Blaney of Proskauer.
Transactional attorneys should consider consulting with litigation counsel when drafting certain contractual provisions — choice of law, choice of forum, attorney fees and others — that could come into play in a broad range of substantive disputes, says Adrienne Koch at Katsky Korins.
The Pennsylvania General Assembly's proposed legislation aiming to protect patients from balance billing would encourage insurers to cut emergency physicians out of their networks, driving down hospitals' reimbursements and jeopardizing patient care, says Richard Hamilton of Drexel University's College of Medicine.